- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06385626
The Effects of Raspberry Leaf Tea on Blood Glucose Control (RLT)
The Effects of Raspberry Leaf Tea on Blood Glucose Control in Healthy Adults
The aim of the present clinical trial is to assess how raspberry leaf polyphenols impact on postprandial glucose and insulin levels in healthy individuals consuming sucrose.
The questions the project will address:
- Do raspberry leaf polyphenols lower sucrose-induced increases in plasma glucose in humans?
Do these polyphenols mediate these effects by inhibiting digestion of sucrose or the absorption of glucose.
20 healthy adults will be recruited between the ages of 18-65 years who are non-smokers and not taking certain types of medication (e.g., drugs from a GP for high blood pressure, high blood fats, inflammatory conditions, and depression) or dietary supplements (e.g., cholesterol-lowering spreads, fish oil, probiotics, prebiotics, and natural laxatives), antibiotics in the last three months or if they used any drugs or supplements that could affect their blood glucose or lipid metabolism. No abnormal results for liver function tests, renal function tests, and lipid profile tests. If they have food allergies or consume more than 14 units of alcohol per week (i.e., to help they calculate a alcohol intake, one standard glass of wine (175 ml) or one pint of regular lager is equivalent to just over two units of alcohol), frequently travel for work or are participating in another intervention study, they will not be able to participate. Women who are pregnant or lactating or planning a pregnancy in the next six months will also not be able to take part, not use herbal medicines for at least the previous three months, not be on a weight loss program six months before screening, not involved in clinical trials six months before the screening, and not having severe cardiac, hepatic, or renal function impairment. Not Sufferers of chronic illnesses, not Individuals with food allergies, not people with coeliac disease.
They will be asked to attend a four-study visit after an eight-hour overnight fast. Volunteers will be asked to consume 50 g of carbohydrate powder (sucrose and glucose) with or without 10 g of raspberry leaf tea, which will be dissolved in 300 mL of warm water during four visits (every month). Blood samples will be taken at intervals for a period of two hours after the consumption of raspberry leaf or control. Blood glucose and insulin levels will be tested 15 minutes before, at 15,30,60,90, and 120 minutes after carbohydrate intake.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The volunteer inclusion criteria are: (Fasting blood glucose in the range < 5.5 mmol/l (at day 0); A signed consent form; Age 18-65 years; Body mass index ≤ 34.9 kg/m2; Non-smoking; No pregnancy/lactation; No use of herbal medicines for at least the previous three months; Not on a weight loss program six months before screening; Not involved in clinical trial six months before screening; Not had severe cardiac, hepatic, or renal function impairment).
The volunteer exclusion criteria are: (Smoking, Pregnancy/lactation; Use of herbal medicines for at least the previous three months; Involved in a weight loss program six months before screening; Involved in clinical trial six months before the screening; Had severe cardiac, hepatic, or renal function impairment; Sufferers of chronic illnesses; Individuals with food allergies; People with prediabetes or diabetes; People with coeliac disease)
If all subjects are generally healthy, as demonstrated by their medical history and laboratory tests, including fasting blood sugar and insulin levels, as well as HOMA-IR, liver function tests (alanine transaminase, alkaline phosphatase, total bilirubin, and gamma-GT), renal function tests (uric acid and creatinine), and lipid profile tests (total cholesterol, Triglycerides). They will be asked to attend a four-study visit after an eight-hour overnight fast. Volunteers will be asked to consume 50 g of carbohydrate powder (sucrose and glucose) with or without 10 g of raspberry leaf tea, which will be dissolved in 300 mL of warm water during four visits (every month). Blood samples will be taken at intervals for a period of two hours after the consumption of raspberry leaf or control. Blood glucose and insulin levels will be tested 15 minutes before, at 15,30,60,90, and 120 minutes after carbohydrate intake.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jeremy Spencer, PhD
- Phone Number: 01183788724
- Email: j.p.e.spencer@reading.ac.uk
Study Locations
-
-
Berkshire
-
Reading, Berkshire, United Kingdom, RG6 5SG
- Recruiting
- Hugh Sinclair Unit of Human Nutrition, University of Reading
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
The volunteer inclusion criteria are:
- Fasting blood glucose in the range < 5.5 mmol/l (at day 0)
- A signed consent forms.
- Age 18-65 years
- Body mass index ≤ 34.9 kg/m2
- Non-smoking
- No pregnancy/lactation
- No use of herbal medicines for at least the previous three months
- Not on a weight loss program six months before screening
- Not involved in clinical trial six months before screening
- Not had severe cardiac, hepatic, or renal function impairment
The volunteer exclusion criteria are:
- Smoking
- Pregnancy/lactation
- Use of herbal medicines for at least the previous three months
- Involved in a weight loss program six months before screening.
- Involved in clinical trial six months before the screening.
- Had severe cardiac, hepatic, or renal function impairment.
- Sufferers of chronic illnesses
- Individuals with food allergies
- People with prediabetes or diabetes
- People with coeliac disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: sucrose + raspberry leaf tea
Volunteers will be asked to consume 50 g of sucrose with 10 g of raspberry leaf tea dissolved in 300 mL of warm water.
|
10 g of raspberry leaf tea
|
|
Experimental: glucose + raspberry leaf tea
Volunteers will be asked to consume 50 g of glucose with10 g of raspberry leaf tea dissolved in 300 mL of warm water.
|
10 g of raspberry leaf tea
|
|
Active Comparator: sucrose
Volunteers will be asked to consume 50 g of sucrose without 10 g of raspberry leaf tea
|
10 g of raspberry leaf tea
|
|
Active Comparator: glucose
Volunteers will be asked to consume 50 g of glucose without 10 g of raspberry leaf tea
|
10 g of raspberry leaf tea
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Glucose
Time Frame: Two hours
|
Area under the plasma glucose curve 0-120 minutes
|
Two hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jeremy Spencer, PhD, University of Reading
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UREC: 23_15-Raspberry Leaf Tea
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type II Diabetes
-
Microbio Co LtdCompleted
-
University of Malagaclinical professorNot yet recruiting
-
pico-tesla Magnetic Therapies, LLCCompletedType II Diabetes MellitusUnited States
-
KeyBioscience AGEli Lilly and Company; Profil Institut für Stoffwechselforschung GmbH; Nordic...TerminatedType II Diabetes MellitusGermany
-
Baqai Institute of Diabetology and EndocrinologyNational Institute for Health Research, United Kingdom; University of York; Aga... and other collaboratorsRecruitingType II Diabetes MellitusPakistan
-
HealthInsightCenter for Technology and Aging; VoxivaUnknownType II Diabetes MellitusUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Khoo Teck Puat HospitalCompletedType II Diabetes in Subjects BMI 27 to 32Singapore
-
University of PretoriaNestlè Nutrition Institute Africa; South African Sugar AssociationCompletedDiabetes Mellitus, Type II [Non-insulin Dependent Type] [NIDDM Type] UncontrolledSouth Africa
Clinical Trials on Raspberry leaf tea
-
Atlantia Food Clinical TrialsCompletedOsteoarthritis, KneeIreland
-
Instituto Politécnico de BragançaRecruiting
-
University of Veterinary and Animal Sciences, Lahore...CompletedSmall Intestinal Bacterial Overgrowth | Gastrointestinal Disorder, FunctionalPakistan
-
University of the AegeanActive, not recruitingOxidative Stress | Inflammation BiomarkersGreece
-
Instituto Politécnico de BragançaEuropean Social Fund; Unidade Local de Saude do NordesteEnrolling by invitation
-
Ahmed TalibCompleted
-
The Cleveland ClinicOhio State University Comprehensive Cancer CenterCompletedFamilial Adenomatous PolyposisUnited States
-
Bezmialem Vakif UniversityAlbayraklar FoundationCompleted
-
Clinical Nutrition Research Center, Illinois Institute...Completed
-
Ain Shams UniversityCompleted